Clinical Trials Logo

Rabies Virus Infection clinical trials

View clinical trials related to Rabies Virus Infection.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05382650 Recruiting - Pediatrics Clinical Trials

Survey of Human Rabies Immune Globulin Safety in Children

Start date: February 22, 2023
Phase:
Study type: Observational

This observational study will be conducted across the Houston Methodist system, including all hospital-based and freestanding emergency departments (ED), and up to 4 additional sites in the United States. The safety of human rabies immune globulin (HRIG) 300 IU/mL product (HyperRAB®) in pediatric patients has not been fully established. The purpose of this study is to evaluate the safety of HRIG 300 IU/mL when given to pediatric patients per standard of care for rabies postexposure prophylaxis (PEP) in the ED.